LENZ Therapeutics, Inc.(LENZ)

Biotechnology · Solana Beach, CA

$3.76+0.17 (+4.60%)

Delayed quote: Oct 6, 2026, 3:50 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T19:52:50.641Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:52:50.641Z.

Quote observation: 2026-10-06T19:50:42.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 117,735,749
Total debt · period ending 2026-06-30: 122,000
Cash · period ending 2026-06-30: 24,208,000
TTM free cash flow · period ending 2026-06-30: -114,419,000

FMP input reference: d8f500f051b8c2f6d9df2326c38ce0bcf8edb39987555b97daf7c0f1a95d0fd4

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LENZ EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

LENZ Competitors' EV/FCF Ratio

LENZ

LENZ Therapeutics, Inc.

Current

Market Cap

$117.74M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SPRB

Spruce Biosciences, Inc.

vs LENZ

Market Cap

$118.40M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGM

BGM Group Ltd.

vs LENZ

Market Cap

$118.56M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TNYA

Tenaya Therapeutics, Inc.

vs LENZ

Market Cap

$119.44M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FHTX

Foghorn Therapeutics Inc.

vs LENZ

Market Cap

$114.86M

EV/FCF Ratio

N/A

TTM Avg

1.44x

3Y Avg

1.44x

5Y Avg

1.44x

SEER

Seer, Inc.

vs LENZ

Market Cap

$120.13M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CBUS

Cibus, Inc.

vs LENZ

Market Cap

$120.99M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUCD

Lucid Diagnostics Inc.

vs LENZ

Market Cap

$114.48M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COYA

Coya Therapeutics, Inc.

vs LENZ

Market Cap

$114.47M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENGN

enGene Holdings Inc.

vs LENZ

Market Cap

$121.25M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
LENZ Therapeutics, Inc. (LENZ)	$117.74M	N/A	N/A	N/A	N/A
Spruce Biosciences, Inc. (SPRB)vs ›	$118.40M	N/A	N/A	N/A	N/A
BGM Group Ltd. (BGM)vs ›	$118.56M	N/A	N/A	N/A	N/A
Tenaya Therapeutics, Inc. (TNYA)vs ›	$119.44M	N/A	N/A	N/A	N/A
Foghorn Therapeutics Inc. (FHTX)vs ›	$114.86M	N/A	1.44x	1.44x	1.44x
Seer, Inc. (SEER)vs ›	$120.13M	N/A	N/A	N/A	N/A
Cibus, Inc. (CBUS)vs ›	$120.99M	N/A	N/A	N/A	N/A
Lucid Diagnostics Inc. (LUCD)vs ›	$114.48M	N/A	N/A	N/A	N/A
Coya Therapeutics, Inc. (COYA)vs ›	$114.47M	N/A	N/A	N/A	N/A
enGene Holdings Inc. (ENGN)vs ›	$121.25M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

LENZ EV/FCF Ratio Metrics

LENZ Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics